Profile for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.196   -0.0046 (-2.29%) Volume: 1.14m 3:39 PM EDT 31-Mar-2020
Business Description:
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.
Address: 275 Madison Avenue, 7th Floor, New York, NY, USA, 10016
Telephone: +1 646 677-3870 Website:
Facsimile: +1 845 818-3588 Email: [email protected]
CEO: Sandesh Seth
Employees: 30 Market Cap: 32.28m
Issue Type: CS
Auditor: Marcum LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1388320
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)